Loading...

Aspira Women's Health Inc.

AWHNASDAQ
Healthcare
Medical - Diagnostics & Research
$0.08
$0.00(0.00%)

Aspira Women's Health Inc. (AWH) Stock Competitors & Peer Comparison

See (AWH) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
AWH$0.08+0.00%2.9M-0.09-$0.93N/A
DHR-PB$1,261.26-0.78%916.8B146.01$8.64+0.57%
TMO$478.32+0.69%180.5B27.66$17.29+0.34%
DHR$205.48+1.32%147.2B43.63$4.71+0.57%
IDXX$565.19+2.77%45.5B52.19$10.83N/A
A$120.18-0.14%34.1B29.60$4.06+0.81%
IQV$199.17-0.82%33.9B28.88$6.90N/A
MTD$1,263.99+0.26%26.2B31.50$40.09N/A
NTRA$138.90-1.53%19B-94.49-$1.47N/A
DGX$168.55-1.95%18.8B20.19$8.35+1.84%
Showing 1 to 10 of 89 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

AWH vs DHR-PB Comparison July 2025

AWH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AWH stands at 2.9M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, AWH is priced at $0.08, while DHR-PB trades at $1,261.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AWH currently has a P/E ratio of -0.09, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, AWH's ROE is +4.66%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, AWH is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for AWH.Check DHR-PB's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;